Clinical outcomes for ibrutinib in relapsed or refractory mantle cell lymphoma in real-world experience.
Cancer Med. 2019 Nov;8(16):6860-6870. doi: 10.1002/cam4.2565. Epub 2019 Sep 27.
Cancer Med. 2019.
PMID: 31560165
Free PMC article.